Myriad Genetics sees FY13 EPS at high end of previous range $1.55 -$1.58 Consensus for FY13 EPS is $1.57. Myriad Genetics sees FY13 revenue to be at the high end of the previous range $575M-$585M. Consensus for FY13 revenue is $583.30M.
News For MYGN From The Last 14 Days
Check below for free stories on MYGN the last two weeks.